ÂÜÀòÂÒÂ×

Angela Ni is a professional in healthcare venture capital, currently working at Bioluminescence Ventures since 2022, focusing on therapeutics, medtech, and tech bio from Series A to C. Prior experience includes a position in healthcare investment banking at Goldman Sachs from 2021 to 2022 and biotech investment research at Evercore from 2019 to 2021, specifically on the SMID-Cap Biotech team. Angela Ni holds a dual degree in Biophysics and Economics (Finance) from The Wharton School, under the Roy & Diana Vagelos Program in Life Sciences & Management.